Prevalence of Hypogonadism in Low-Risk Prostate Cancer Survivors.
Fed Pract
; 33(Suppl 4): 37S-43S, 2016 05.
Article
em En
| MEDLINE
| ID: mdl-30766218
ABSTRACT
Increasing evidence, albeit small, suggests that testosterone replacement therapy can be cautiously considered in selected hypogonadal men treated with curative intent for low-risk prostate cancer and without evidence of active disease.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article